Life sciences dealmaking came back in 2025, and artificial intelligence is poised to drive even more M&A activity in 2026 as companies move from hyping the technology to proving its value in drug ...

Swiss biotech in particular saw strong activity in 2025 with the establishment of 15 new life sciences companies. In January, several Swiss life sciences start-ups announced significant financings and ...

Delaware has seen a 65% increase in new biotechnology companies over the past decade, according to a recent report by the Delaware BioScience Association and the Delaware Prosperity Partnership. This ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Demand is high for lab space in ...

Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life ...

Alisha Hines graduated from an eight-week program in biomanufacturing and life sciences earning what's known as a "microcredential." (Jesse Costa/WBUR) On a recent afternoon at Northeastern University ...

Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...

Life sciences leaders say AI agents will be "essential" within two years. 97% say trusted data is essential for effective use of AI agents. 81% of R&D leaders surveyed are "very excited" about using ...

The focus of Life Sciences Week (LSW) 2026 is “delivery of improved health outcomes and economic growth,” organisers told a ‘preview’ event in Birmingham today.